MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced that ...
23 小时on MSN
Is India’s exam system really secure? NTA portal breached, superadmin access bypassed ...
Dubai-based cybersecurity researcher Rylan Anil has claimed that he identified a major security lapse in the NTA’s official ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果